Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2011 Jul 6;(7):CD002137. doi: 10.1002/14651858.CD002137.pub2
Methods RCT
Participants Women with severe cyclical mastopathy for at least 5 years (Canada)
CVD risk: low
Control: randomised 10, analysed 9
Intervention: randomised 11, analysed 10
Mean years in trial: control 0.45, intervention 0.45
% male: 0%
Age: mean control 36, intervention 38 (variances unclear)
Interventions Reduced fat vs usual diet
Control aims: given principles of healthy diet, not counselled to alter fat content
Intervention aims: total fat 15%E, CHO 65%E
Control methods: seen every 2 months to monitor symptoms, nutrition and biochemistry
Intervention methods: seen monthly to monitor symptoms, nutrition and biochemistry, teaching materials included food guide, recipes, product information and advice on eating out
Total fat intake (at 6 months): low fat 22.8 (sd unclear), cont 33.4 (sd unclear)%E
Saturated fat intake (at 6 months): low fat 8.8 (sd unclear), cont 12.3 (sd unclear)%E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: mastopathy symptoms, plasma hormone and lipids
Data available on total mortality? yes (no events)
Cardiovascular mortality? yes (no events)
Events available for combined cardiovascular events: none
Secondary outcomes: cancer deaths (none)
Tertiary outcomes: total cholesterol (but variance data not provided)
Notes Total cholesterol rose by 0.09mmol/L in control group (from 4.5 to 4.59) and fell by 0. 15mmol/L in intervention group (4.84 to 4.69)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection bias) Low risk “randomly allocated”
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly described
Blinding (performance bias and detection bias)
All outcomes
High risk Participants were not blinded, those assessing physical outcomes were blinded, those assessing symptoms were not
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear, deaths, cancer and CV events are drop-outs, trialists asked for data - unclear if any data missing
Selective reporting (reporting bias) Low risk Not relevant for primary and secondary outcomes as all trialists asked for data
Other bias Low risk
Free of systematic difference in care? High risk Minor differences in follow up frequency. See Control and Intervention Methods in Interventions section of the Table of Characteristics of Included Studies
Free of dietary differences other than fat? Low risk See Control and Intervention Aims in Interventions section of the Table of Characteristics of Included Studies